ATI
LLY icon

Act Two Investors’s Eli Lilly LLY Stock Holding History

Act Two Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.52M Sell
8,174
-266
-3% -$270K 1.66% 17
2025
Q4 		$9.07M Sell
8,440
-9
-0.1% -$8.61K 1.63% 17
2025
Q3 		$6.45M Buy
+8,449
New +$6.29M 1.14% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Act Two Investors's LLY Position: Q1 2026 in Review

Act Two Investors reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $270K and leaving 8,174 shares worth $7.52M. The position accounts for 1.66% of the portfolio, ranked #17.

Act Two Investors first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. The position peaked at $9.07M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Act Two Investors held 8,174 shares of Eli Lilly worth $7.52M as of Q1 2026.
  • Act Two Investors sold 266 Eli Lilly shares in Q1 2026, an estimated $270K.
  • Eli Lilly made up 1.66% of Act Two Investors's portfolio in Q1 2026, its #17 holding.
  • Act Two Investors first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • Act Two Investors's Eli Lilly position peaked at $9.07M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Act Two Investors's 13F filing for Q1 2026, filed 8 May 2026.